Sotac Pharmaceuticals Ltd brings its IPO on 28th March, To be listed on NSE Emerge Platform

Ahmedabad (Gujarat) [India], March 28: Ahmedabad based Sotac Pharmaceuticals Ltd. specializes in the production of high-quality pharmaceutical products on a loan license or contract manufacturing basis. The company has announced its IPO for 30,00,000 shares, where the price band per equity share will be Rs 105 to Rs 111, with each equity share bearing a face value of Rs 10. The shares will be sold in lot size of 1200 shares. Out of the 30,00,000 shares, 14,23,200 shares will be reserved for the QIB quota (including Anchor Reservation), 4,28,400 shares will be reserved for HNI quota, 9,98,400 shares will be reserved for the retail quota and 1,50,000 shares will be reserved under the market maker quota. The issue opens on the 28th March for the Anchor and on the 29th March for the public. The issue closes on the 3rd April, 2023. It will subsequently be listed on the NSE Emerge platform. Beeline Capital Advisors Pvt. Ltd. is the lead manager to the issue and KFin Technologies Ltd. is the registrar to the issue.

The issue proceeds will be utilised for the following:

  • To meet working capital requirements
  • Investment in subsidiary
  • Upgradation/Construction of existing/new building in the existing premises
  • General corporate purpose
  • Issue expenses

Sotac Pharmaceuticals has a diverse product portfolio that includes a wide range of pharmaceuticals, nutraceuticals, and food products. Their state-of-the-art manufacturing facility enables them to produce high-quality products, including tablets, capsules, oral liquids, dry syrups, and external preparations such as ointments, lotions, and creams. The manufacturing unit I is located in Sanand GIDC-Il, Ahmedabad district. The facility features a comprehensive production unit, quality control department, microbiological laboratory, and storage for raw materials and finished products has been approved by the World Health Organization’s Good Manufacturing Practices (WHO GMP) standards. The manufacturing unit II is also located in Sanand GIDC-Il, Ahmedabad district for Beta Lactam products has been approved by the World Health Organization’s Good Manufacturing Practices (WHO GMP) standards. The manufacturing plant operates at the highest safety and environmental standards, ensuring the necessary isolation and differentiation of processes and sections to minimize the chances of cross-contamination. Its impressive client list includes Cadila Pharmaceuticals, Intas, Ronak Health Care, Sunrest Lifesciences, Lincoln Pharmaceuticals, Treatwell Pharma and many more. The company’s products have a pan India and global presence.

The Company has recently completed capacity expansion and has an upcoming facility in its subsidiary, Sotac Lifesciences Private Limited, providing significant room for growth. Utilization of existing unutilized capacities is expected to improve return ratios. The company has well equipped R&D capabilities, in wholly owned subsidiary Sotac Research Private Limited. The company’s progress is backed by its experienced promoters of diverse backgrounds with a combined experience of over 59 years in various industries. Their leadership, guidance and strategic oversight play a pivotal role in driving the company’s success and growth.

Sotac Pharmaceuticals has recorded impressive financial growth over the years. Its consolidated revenue from operations for 6MFY23 was Rs 39.75 crores, while it was Rs 73.15 crores for FY22 and Rs 48.84 crores for FY21. Its consolidated EBITDA for 6MFY23 was Rs 3.68 crores, while it was Rs 6.14 crores for FY22 and Rs 1.46 crores for FY21. The company registered a consolidated PAT of Rs 0.47 crores for 6MFY23, which was Rs 2.88 crores for FY22.

The promoters of the company are Mr Sharadkumar Dashrathbhai Patel, Mr Dineshkumar Babulal Gelot, Mr Vishalkumar Devrajbhai Patel, Mr Chetankumar Bachubhai Patel and Mrs Kiran Baldevbhai Jotania.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Related Posts

Business Excellence Awards 2024 organized by Corporate Connect

New Delhi (India), May 25: It is time to recognize and celebrate the extraordinary business innovation and entrepreneurship achievements. Corporate Connect is thrilled to announce the winners of its highly…

IB Group Emerges as Top 5 Poultry Company in Asia

New Delhi (India), May 25: In a resounding testament to its remarkable growth trajectory, IB Group, in collaboration with Aviagen®, proudly announces a significant milestone: the acquisition of 100,000 Grandparent Poultry (GP) stock in a…

You Missed

Dr. Krishna Kumar Mourya ji has selflessly served cows for 20 years and has set a world record by conducting post-mortems of more than 3000 cows

  • May 25, 2024
Dr. Krishna Kumar Mourya ji has selflessly served cows for 20 years and has set a world record by conducting post-mortems of more than 3000 cows

Flomic Global Logistics Achieves Landmark Milestone with Make in India Gondola Freight Wagons Shipment to Africa

  • May 25, 2024
Flomic Global Logistics Achieves Landmark Milestone with Make in India Gondola Freight Wagons Shipment to Africa

Morepen Labs Profit surges 143 percent while Revenue grows 20 percent in FY24, Dr. Morepen Medical Devices sales soar by 35 percent

  • May 25, 2024
Morepen Labs Profit surges 143 percent while Revenue grows 20 percent in FY24, Dr. Morepen Medical Devices sales soar by 35 percent

Testronix Instruments Announces Revolutionary Testing Solutions

  • May 24, 2024
Testronix Instruments Announces Revolutionary Testing Solutions

SEO on a Budget, This Free Toolkit is All You Need

  • May 24, 2024
SEO on a Budget, This Free Toolkit is All You Need

Orientation Training Programme for Arb-Med

  • May 24, 2024
Orientation Training Programme for Arb-Med